Ten days of 24-hour continuous subcutaneous infusion of a novel levodopa/carbidopa prodrug (ABBV-951) shows a skin safety and tolerability profile similar to saline
EUROPEAN JOURNAL OF NEUROLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要